首页 › 基金 › Ally Bridge Group (NY) LLC › EWTX

Ally Bridge Group (NY) LLC 对 EWTX 的持仓历史

EDGEWISE THERAPEUTICS INC · 医疗保健

Ally Bridge Group (NY) LLC 在 Q3 2026 的 13F 申报中披露持有 EWTX(EDGEWISE THERAPEUTICS INC)185,430 股,市值约 US$7.5M,约占其申报组合的 10.00%,在其申报持仓中市值排名第 3 位。 Ally Bridge Group (NY) LLC 最近 9 个申报季度中有 7 个季度披露了 EWTX 持仓,最早可追溯至 Q3 2024。

最新持仓 (Q3 2026)185.43K 股
申报持仓市值$7.53M
组合权重10.00%
首次申报Q3 2024
最近变动增持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Ally Bridge Group (NY) LLC 对 EWTX 的持仓演变

Ally Bridge Group (NY) LLC 于 Q3 2024 首次披露 EWTX 持仓:187,695 股(约 US$5.0M)。 该持仓在 Q3 2026 达到峰值 185,430 股,市值约 US$7.5M。 在 7 次申报中,Ally Bridge Group (NY) LLC 2 次增持、3 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 185,430 股、市值约 US$7.5M,环比增持 102,130 股。。 持仓曾出现大幅变动:Q4 2024 减持约 56% (随后一个季度股价下跌 18%)、Q2 2026 减持约 48% (随后一个季度股价基本持平)、Q3 2026 增持约 123% (随后一个季度股价上涨 8%)。

逐季持仓明细

季度股数金额变化
Q3 2024 187.69K $5.01M 新进
Q4 2024 83.18K $2.22M 减持
Q1 2025 100.00K $2.20M 增持
Q4 2025 195.00K $4.84M 新进
Q1 2026 161.00K $5.07M 减持
Q2 2026 83.30K $3.38M 减持
Q3 2026 185.43K $7.53M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 EWTX 与 13F 数据

EWTX(EDGEWISE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 EWTX,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$630.1M), Paradigm Biocapital Advisors LP (US$437.6M), RA CAPITAL MANAGEMENT, L.P. (US$340.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 EWTX 的基金

查看 EWTX 的全部基金持有人 →

常见问题

How long has Ally Bridge Group (NY) LLC held EWTX?

Ally Bridge Group (NY) LLC has disclosed EWTX holdings in 7 of the last 9 reported quarters, going back to Q3 2024.

What is Ally Bridge Group (NY) LLC's current position in EWTX?

As of Q3 2026, Ally Bridge Group (NY) LLC holds 185.43K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $7.53M, representing 10.00% of its reported portfolio and ranking #3.

Has Ally Bridge Group (NY) LLC been buying or selling EWTX?

In the latest 13F filing (Q3 2026), Ally Bridge Group (NY) LLC increased its position in EWTX. The position peaked in Q3 2026 at 185.43K shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.